Like IFX, ADA is transferred across the placenta in the third trimester of pregnancy [31,76], and accordingly, it has been recommended at many IBD centers that ADA should be discontinued in the third trimester (that is, week 30), even though data, as mentioned before, do not support this theory [82]. The gene discussed is ADA; the disease is inflammatory bowel disease.